Key result
Atorvastatin effects on carotid and femoral artery compliance and IMT remain undetermined.
Why the study?
The effects of atorvastatin treatment on common carotid and femoral artery intima-media thickness and arterial compliance in premenopausal dyslipidemic women were not well characterized.
Does atorvastatin 80 mg/day improve common carotid and femoral artery IMT and arterial compliance in premenopausal women with dyslipidemia?
Does atorvastatin 80 mg/day improve common carotid and femoral artery IMT and arterial compliance in premenopausal women with dyslipidemia?
This study aimed to evaluate the short-term effects of high-dose atorvastatin on arterial compliance and IMT in premenopausal women, though results are missing from the truncated abstract.
Answers are grounded in this paper and cite their sources.
Missing quantitative results preclude clinical interpretation; leaves open whether high-dose atorvastatin improves IMT or compliance in premenopausal dyslipidemic women.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Yurttutan et al. (2018) studied Dyslipidemia (n=40). Atorvastatin vs. Baseline (pre-treatment) was evaluated on Common carotid and femoral artery intima media thickness (IMT) and arterial compliance.
Synapse has enriched 10 related papers. Consider them for comparative context: